More reports are surfacing of off-target effects from obesity drugs, alongside a push at HHS to move drug development faster.
Recap by typeshit. Full story at PharmaVoice.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Novo also presented liver fat data from STEP-UP and an Ozempic vs Mounjaro heart risk analysis, and paid $300 million upfront for Hengrui's HRS-1596.
Pink Sheet editors say FDA reviewers warn the peptides lack clinical testing, and some career staff may quit if the order goes ahead.
Loading…